MCKENNA MOE: Open Payments
NPI 1124691712 · GAINESVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,724 in 130 payments from 19 companies in 2025. Trend: 2023 $1,135 · 2024 $2,514 · 2025 $2,724
Food & beverage: $2,724
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $534 |
| Janssen Biotech, Inc. | 12 | $271 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 11 | $232 |
| Regeneron Healthcare Solutions, Inc. | 9 | $226 |
| Lilly USA, LLC | 13 | $205 |
| Madrigal Pharmaceuticals | 4 | $193 |
| GENZYME CORPORATION | 7 | $177 |
| PFIZER INC. | 12 | $174 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $148 |
| Ipsen Biopharmaceuticals, Inc | 6 | $126 |
Products named: DUPIXENT, TREMFYA, XIFAXAN, OMVOH, REZDIFFRA, SKYRIZI, IQIRVO, MAVYRET.
Industry payments across GA — which companies pay providers there.
